How we help

Enterprise Strategy

Strategy built to maximize long-term enterprise valuation

Overview

Enduring enterprise value is not created by planning alone, but by the right strategic choices, sustained over time, and backed by disciplined capital and execution.

We partner with CEOs and senior leadership teams to sharpen enterprise strategy with a single objective: maximizing long-term enterprise value. Our work helps leadership teams clarify where value will be created, align capital and resources to that strategy, and execute against the few moves that materially change the company’s performance and valuation trajectory.

Strong strategies already exist in most organizations. We help CEOs make them clearer, more focused, and more value-accretive, so that strategic intent, capital deployment, and execution reinforce one another over time.

Why enterprise strategy matters

Enterprise strategy is the CEO’s most powerful lever for shaping long-term performance. In an environment of heightened investor scrutiny, capital constraints, and rapid competitive change, valuation is increasingly driven by clarity of strategic intent, quality of capital allocation, and the ability to deliver value-defining inflection points.

We help CEOs elevate enterprise strategy from a planning exercise to a system for creating value, one that consistently converts strategic choices into sustained financial performance and long-term value creation.

Where we focus

Enterprise valuation strategy

Defining where the enterprise will compete, and how it will win, to build durable competitive advantage

We help CEOs and boards clarify the strategic choices that most directly influence long-term enterprise value.

  • Define the markets, segments, and capabilities where the enterprise can create disproportionate value
  • Clarify sources of competitive advantage that are durable, defensible, and valued by capital markets
  • Align leadership around a small number of value-defining strategic choices
  • Translate strategic ambition into a coherent narrative for investors and stakeholders

Capital deployment strategy

Aligning capital, resources, and growth bets with value creation priorities

Capital allocation is where strategy becomes real. We help CEOs ensure that investment decisions consistently reinforce enterprise priorities.

  • Assess the full portfolio of businesses and initiatives through a value-creation lens
  • Reallocate capital toward the highest-return opportunities across growth, transformation, and optimization
  • Balance near-term earnings performance with long-term growth
  • Establish repeatable decision frameworks that improve capital discipline over time

Value inflection roadmapping

Translating strategy into execution against value-defining milestones

Sustained growth requires more than broad initiatives. It requires execution against the few moves that materially shift performance and market perception.

  • Identify the critical initiatives and milestones that unlock step-changes in value
  • Sequence initiatives to maximize impact while managing organizational capacity and risk
  • Define clear ownership, metrics, and decision points for value-defining actions
  • Maintain leadership focus on the initiatives that matter most

R&D and innovation portfolio strategy

Turning growth ambition into focused R&D portfolio decisions

We help leadership teams align R&D investment with enterprise strategy, weighing scientific differentiation, patient needs, commercial potential, development risk, and capital requirements.

  • Assess platform and development capabilities against enterprise strategy and focus therapeutic areas
  • Clarify which programs to advance, accelerate, partner, or stop
  • Sequence indications and investment around value-defining milestones
  • Shape a build, buy, and partner strategy to fill critical capability gaps

Client impact

Re-aligning strategy to enhance market valuation

Following a major strategic pivot, a leadership team faced growing misalignment between enterprise strategy, capital allocation, and external perception. While the direction was sound, the organization lacked a clear articulation of how value would be created, and over what timeframe.

We partnered closely with the CEO and executive team to re-anchor enterprise strategy around a coherent value-creation logic. This included clarifying where the company would compete, how it would win, and which near-term value inflection points mattered most. We then rebuilt the strategic narrative to align leadership, board, and investors around a shared view of priorities and capital deployment.

The result was renewed strategic clarity, more confident board engagement, and a defensible path to long-term value creation, enabling leadership to shift from explaining the pivot to executing it.

Focusing R&D capital on the highest-value programs

An AI-enabled drug discovery company was building a proprietary platform alongside an internal pipeline, pharma partnerships, and a services business. Each competed for the same capital and scientific talent, yet decisions across them were made separately, with no common logic for allocating capital.

We partnered closely with the CEO and executive team to build an integrated strategy across the platform, pipeline, partnerships, and services. This included assessing platform capabilities and gaps, selecting focus therapeutic areas, and prioritizing programs on unmet need, scientific merit, competition, and commercial potential. We then used build-buy-partner analysis to define an acquisition agenda tied to specific value drivers, and focused business development on the partners that best fit the platform strategy.

The result was a focused portfolio of internal and partnered programs, multiple acquisitions that filled key capability gaps, and a major pharma partnership that funded and validated the platform.

How we deliver

Our approach is designed for CEOs: rigorous, pragmatic, and relentlessly focused on long-term enterprise value.

  1. 1

    Anchor on value and strategic ambition

    • Align with the CEO and board on objectives, time horizon, and success criteria
    • Ground the work in enterprise performance, capital market expectations, and strategic constraints
    • Establish a shared ambition for long-term value creation
  2. 2

    Diagnose value creation across the enterprise

    • Assess portfolio performance, competitive positioning, and sources of advantage
    • Identify where value is being created, constrained, or diluted today
    • Surface the strategic and capital trade-offs requiring leadership attention
  3. 3

    Define value-creating strategic choices

    • Develop a focused set of strategic options tied directly to performance and value
    • Stress-test choices against financial, operational, and organizational realities
    • Support CEO and top-team decision-making on where to play and how to win
  4. 4

    Align capital and resources to strategy

    • Translate strategic choices into capital allocation and investment priorities
    • Evaluate trade-offs across businesses, initiatives, and time horizons
    • Define governance mechanisms that sustain alignment over time
  5. 5

    Mobilize execution around value inflection points

    • Identify the few initiatives that will materially move enterprise performance
    • Build a clear roadmap with milestones, metrics, and accountability
    • Support leadership in maintaining focus and momentum against value-defining goals

Other practices

M&A and Integration

We help CEOs use M&A as a repeatable engine for enterprise value creation, from strategy through integration and capability building.

Learn more

Growth and New Ventures

We help CEOs identify, design, and launch new business models and ventures that create differentiated, scalable sources of growth.

Learn more

Hard choices.
Smarter answers.

As your trusted advisors and fractional strategy team, we help you navigate complexity and deliver results that enhance value and build a legacy.